This information is provided by and with permission from PhRMA (Pharmaceutical Research and Manufacturers of America®). This Medicine Assistance Tool (MAT) is a free-to-use search engine that focuses its searches on patient assistance resources available to eligible patients.
PhRMA’s member companies are committed to helping patients make more informed health care decisions by providing more transparency about medicine costs.
PhRMA and MAT have not independently verified, approved or otherwise reviewed this information. The information provided here is subject to change without notice. Please contact the individual companies with questions about the information provided on their websites.
If you don’t see an arrow by each company’s name, click on the name to show the medications with provided information. All links will open in new windows or tabs.
HUMIRA® (adalimumab)
MAVYRET™ (glecaprevir/pibrentasvir)
ORILISSA® (elagolix tablets)
SKYRIZI™ (risankizumab-rzaa)
BOTOX® (onabotulinumtoxinA) Please see full product information including boxed warning and medication guide: https://www.allergan.com/assets/pdf/botox_pi.pdf
LINZESS® (linaclotide)
LO LOESTRIN® FE (norethindrone acetate and ethinyl estradiol, ethinyl estradiol and ferrous fumarate)
VRAYLAR® (cariprazine)
Myrbetriq® (Mirabegron)
BRILINTA® (ticagrelor)
FARXIGA® (dapagliflozin)
FASENRA™ (benralizumab)
SYMBICORT® (budesonide/formoterol fumarate dihydrate)
JARDIANCE® (empagliflozin)
ELIQUIS® (apixaban)
Otezla® (apremilast)
Basaglar® (insulin glargine injection)
Emgality® (galcanezumab-gnlm)
Humalog® (insulin lispro injection)
OLUMIANT® (baricitinib)
Taltz® (Ixekizumab)
Trulicity® (dulaglutide)
Verzenio™ (abemaciclib)
BIKTARVY® (bictegravir/emtricitabine/tenofovir alafenamide)
EPCLUSA® (sofosbuvir/velpatasvir)
TRUVADA (emtricitabine/tenofovir disoproxil fumarate) for PrEP®
ANORO (umeclidinium/vilanterol inhalation powder)
TRELEGY ELLIPTA (fluticasone furoate, umeclidinium, and vilanterol inhalation powder)
COSENTYX® (secukinumab)
ENTRESTO® (sacubitril/valsartan)
Ozempic® (semaglutide)
REXULTI® (brexpiprazole)
Toujeo® (insulin glargine injection)
Latuda® (lurasidone HCl)
ENTYVIO® (vedolizumab)
TRINTELLIX (vortioxetine)
Briviact® (brivaracetam)
Cimzia® (certolizumab pegol)
Neupro® (rotigotine transdermal system)
Vimpat® (lacosamide)
Understanding the full spectrum of ADHD presentations is essential
Shift your focus from specific tasks you complete, like writing code, creating briefs, drafting product…
This article explores the origins of this misconception, what the research actually says, and how…
When parents are not aligned, children with ADHD may exploit inconsistencies—intentionally or not—to avoid tasks,…
By 2025 and 2026, new ADHD treatments will offer more effective symptom management, fewer side…
Receiving a long list of concerns or criticisms about your child from their school can…